Further stratification using adult treatment panel III criteria for metabolic syndrome revealed that PCOS patients with one or more risk factors (59.43%) had higher PPARGC1A methylation and lower mtDNA content than those without risk factors (41.57%). The gene discussed is PPARGC1A; the disease is metabolic syndrome.